2023 · Medicina · paywalled
Hills et al.
Daily remote urine hormone monitoring of LH and PdG, together with age and cycle start day, can identify menstrual cycle phase and day with 95% confidence; this supports precise, patient-centric cycle tracking outside clinic settings.
A paraphrase to the Library’s standard, never the abstract. The source is one link away and is always the authority.
2024
This retrospective case series found that a protocol combining home-based urinary hormone testing with a smartphone application supported fertility management and family planning without unintended pregnancies. The findings suggest that integrating self-collected urinary data with digital tools offers a viable decentralised approach for ovulation prediction.
Helping Patients to Predict and Confirm Ovulation with the Use of Combined Urinary Hormonal and Smartphone Technology: A Proof-of-Concept Retrospective Descriptive Case Series — Leiva & Ecochard, Seminars in reproductive medicine · source ↗
2020
Among 32,595 women trying to conceive using a connected home ovulation test, only 12.4% actually had a 28-day cycle despite 25.3% perceiving they did, and over half had cycles varying by 5 days or more. The findings demonstrate that connected home testing reveals substantial individual variation in cycle length and ovulation timing, which could help women better time intercourse for conception.
Real-life insights on menstrual cycles and ovulation using big data — Soumpasis et al., Human reproduction open · source ↗
2026
Menstrual blood offers a noninvasive, patient-centric matrix for detecting endometriosis, cervical cancer, and hormonal disorders through self-collected samples. Wearable in-pad biosensors enabling real-time monitoring and long-term tracking could transform fertility evaluation and early disease detection, though standardisation and large-scale validation remain critical gaps.
Beyond waste: menstrual blood as a powerful diagnostic tool for women's health — Shafiq et al., Annals of medicine and surgery · source ↗
2025
The Mira fertility monitor's LH surge and urine E1-3G levels correlated strongly with the ClearBlue Fertility Monitor's LH surge and low-to-high shift in both postpartum and perimenopause transitions, supporting at-home urine hormone monitoring for fertility tracking.
Validating At-Home Urinary Hormone Measurements in Postpartum and Perimenopause Fertility Transitions — Bouchard et al., Women's health reports · source ↗
2025
In this decentralised n-of-1 crossover trial of dapagliflozin in 20 adults with type 2 diabetes, remote collection of urine and capillary blood samples achieved 99.4% and 98.4% delivery success respectively, demonstrating that remote monitoring can reliably track individual albuminuria responses to therapy.
Albuminuria Responses to Dapagliflozin in Patients With Type 2 Diabetes: A Crossover Trial — Beernink et al., JAMA network open · source ↗